Natixis Bria Cell Therapeutics Corp. Transaction History

Natixis

  • $17.4 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$5.72 - $7.58 $516,230 - $684,095
90,250 New
90,250 $579,000
Q4 2022

Feb 24, 2023
BUY
$4.28 - $6.73 $53,500 - $84,125
12,500 New
12,500 $54,000

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $14.9M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email